{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:17:27Z","timestamp":1790741847493,"version":"4.1.0"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:sec id=\"ab-eoi260014-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>In bilateral geographic atrophy (GA), enlargement rates in fellow eyes are often assumed to be highly correlated. On this basis, researchers have inferred treatment effects and proposed GA trials using the untreated fellow eye as an internal control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260014-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To quantify the correlation in GA enlargement rates between fellow eyes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260014-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This was a post hoc analysis of Age-Related Eye Disease Study 2 (AREDS2), a multicenter study of patients in retinal specialty clinics throughout the US. Included in the analysis were participants of the AREDS2 trial with bilateral GA. Study data were analyzed from May 2025 to January 2026.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260014-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>GA in the fellow eye.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260014-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Pearson correlation coefficient for 2-year GA enlargement rates in eye pairs. Rates were derived from planimetry of annual fundus photographs and expressed as untransformed, square root\u2013transformed, and perimeter-adjusted rates. Correlation was analyzed overall and within clinically relevant strata.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260014-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 386 eyes of 193 AREDS2 participants (mean [SD] age, 75.5 [7.3] years; 118 female [61.1%]) with bilateral GA were included in this analysis. Correlations in enlargement rates varied substantially by transformation used as follows: moderate for untransformed (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      \u2009=\u20090.51; 95% CI, 0.41-0.61), weak to moderate for square root\u2013transformed (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      \u2009=\u20090.38; 95% CI, 0.25-0.49), and very weak for perimeter-adjusted (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      \u2009=\u20090.11; 95% CI, \u22120.03 to 0.25) rates. Correlation was consistently weaker in large vs small GA: 0.30 (95% CI, 0.07-0.50) vs 0.63 (95% CI, 0.41-0.78; untransformed), 0.38 (95% CI, 0.16-0.56) vs 0.46 (95% CI, 0.20-0.66; square root), and 0.03 (95% CI, \u22120.21 to 0.26) vs 0.22 (\u22120.08 to 0.49; perimeter), respectively. For GA location using untransformed rates, correlation was strongest for extrafoveal GA, intermediate for subfoveal GA, and weakest for discordant pairs. Square root rates showed a similar pattern. For focality using untransformed rates, correlation was similar for unifocal, multifocal, and discordant pairs. Using square root rates, it was strongest for unifocal GA, weakest for multifocal GA, and intermediate for discordant pairs. For reticular pseudodrusen (RPD) status, correlation was strongest for RPD absence, weakest for presence, and intermediate for discordant pairs. Differences were smaller using square root rates.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260014-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Results of this post hoc analysis of the AREDS2 trial reveal that correlation in GA enlargement rates between fellow eyes was modest. Key GA characteristics of area, location, focality, and RPD status, as well as the transformation used, were strongly associated with the correlation. Untransformed rates were inflated by a tendency for symmetry in baseline GA characteristics, whereas genuine biological correlation (best reflected by linear enlargement) was only weak to moderate. Researchers should be cautious of trials and analyses relying on assumptions of highly correlated enlargement rates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2026.0540","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:30:37Z","timestamp":1775143837000},"page":"433","source":"Crossref","is-referenced-by-count":8,"title":["Modest and Variable Correlations Between Geographic Atrophy Enlargement Rates in Fellow Eyes in the AREDS2 Study"],"prefix":"10.1001","volume":"144","author":[{"given":"Leon","family":"von der Emde","sequence":"first","affiliation":[{"name":"Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland"},{"name":"Department of Ophthalmology, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Vance","sequence":"additional","affiliation":[{"name":"Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souvick","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintong","family":"Hou","sequence":"additional","affiliation":[{"name":"Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Agr\u00f3n","sequence":"additional","affiliation":[{"name":"Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fares","family":"Siddig","sequence":"additional","affiliation":[{"name":"Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitha","family":"Domalpally","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison School of Medicine and Public Health, Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Chakravarthy","sequence":"additional","affiliation":[{"name":"Centre for Public Health, Queen\u2019s University Belfast, Belfast, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Y.","family":"Chew","sequence":"additional","affiliation":[{"name":"Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiarn\u00e1n D. L.","family":"Keenan","sequence":"additional","affiliation":[{"name":"Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"AREDS2 Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"eoi260014r1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ophtha.2006.09.016","article-title":"The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials.","volume":"114","author":"Sunness","year":"2007","journal-title":"Ophthalmology"},{"issue":"5","key":"eoi260014r2","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.ajo.2008.05.050","article-title":"The epidemiology of progression of pure geographic atrophy: the Beaver Dam Eye Study.","volume":"146","author":"Klein","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"eoi260014r3","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2023.100318","article-title":"Progression of geographic atrophy: retrospective analysis of patients from the IRIS Registry (Intelligent Research in Sight).","volume":"3","author":"Rahimy","year":"2023","journal-title":"Ophthalmol Sci"},{"issue":"7","key":"eoi260014r4","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1001\/jamaophthalmol.2021.1407","article-title":"Enlargement of geographic atrophy from first diagnosis to end of life.","volume":"139","author":"Colijn","year":"2021","journal-title":"JAMA Ophthalmol"},{"issue":"9","key":"eoi260014r5","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1001\/archophthalmol.2009.198","article-title":"Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26.","volume":"127","author":"Lindblad","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"eoi260014r6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1167\/iovs.09-3547","article-title":"Concordance of disease progression in bilateral geographic atrophy due to AMD.","volume":"51","author":"Fleckenstein","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"eoi260014r7","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1007\/s40123-023-00798-7","article-title":"Evaluating the effects of C3 inhibition on geographic atrophy progression from deep-learning OCT quantification: a split-person study.","volume":"12","author":"Fu","year":"2023","journal-title":"Ophthalmol Ther"},{"issue":"5","key":"eoi260014r8","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1001\/archopht.120.5.579","article-title":"Symmetry of bilateral lesions in geographic atrophy in patients with age-related macular degeneration.","volume":"120","author":"Bellmann","year":"2002","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"eoi260014r9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00417-010-1483-x","article-title":"The symmetry of phenotype between eyes of patients with early and late bilateral age-related macular degeneration (AMD).","volume":"249","author":"Mann","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"eoi260014r10","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1016\/j.ophtha.2012.05.027","article-title":"The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).","volume":"119","author":"Chew","year":"2012","journal-title":"Ophthalmology"},{"issue":"7","key":"eoi260014r11","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1167\/iovs.13-11804","article-title":"Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 report number 2).","volume":"54","author":"Danis","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"eoi260014r12","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.ophtha.2016.06.025","article-title":"Evaluation of geographic atrophy from color photographs and fundus autofluorescence images: Age-Related Eye Disease Study 2 report number 11.","volume":"123","author":"Domalpally","year":"2016","journal-title":"Ophthalmology"},{"issue":"12","key":"eoi260014r13","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.ophtha.2018.05.028","article-title":"Progression of geographic atrophy in age-related macular degeneration: AREDS2 report number 16.","volume":"125","author":"Keenan","year":"2018","journal-title":"Ophthalmology"},{"issue":"12","key":"eoi260014r14","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1001\/jamaophthalmol.2025.3979","article-title":"Geographic atrophy multifocality in the Age-Related Eye Disease Study 2.","volume":"143","author":"von der Emde","year":"2025","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"eoi260014r15","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1093\/jamia\/ocaa302","article-title":"Multimodal, multitask, multiattention (M3) deep learning detection of reticular pseudodrusen: Toward automated and accessible classification of age-related macular degeneration.","volume":"28","author":"Chen","year":"2021","journal-title":"J Am Med Inform Assoc"},{"issue":"2","key":"eoi260014r16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/ng.3448","article-title":"A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants.","volume":"48","author":"Fritsche","year":"2016","journal-title":"Nat Genet"},{"issue":"12","key":"eoi260014r17","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1016\/j.ophtha.2020.05.036","article-title":"Deep learning automated detection of reticular pseudodrusen from fundus autofluorescence images or color fundus photographs in AREDS2.","volume":"127","author":"Keenan","year":"2020","journal-title":"Ophthalmology"},{"issue":"3","key":"eoi260014r18","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2023.100306","article-title":"Geographic atrophy in age-related macular degeneration: a tale of 2 stages.","volume":"3","author":"Keenan","year":"2023","journal-title":"Ophthalmol Sci"},{"issue":"2","key":"eoi260014r19","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ophtha.2023.09.013","article-title":"Critical dependence on area in relationship between ARMS2\/HTRA1 genotype and faster geographic atrophy enlargement: Age-Related Eye Disease Study 2 report number 33.","volume":"131","author":"Agr\u00f3n","year":"2024","journal-title":"Ophthalmology"},{"issue":"5","key":"eoi260014r20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126636","article-title":"Clinical and genetic factors associated with progression of geographic atrophy lesions in age-related macular degeneration.","volume":"10","author":"Grassmann","year":"2015","journal-title":"PLoS One"},{"issue":"10411","key":"eoi260014r21","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","article-title":"Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): 2 multicenter, randomized, double-masked, sham-controlled, phase 3 trials.","volume":"402","author":"Heier","year":"2023","journal-title":"Lancet"},{"issue":"10411","key":"eoi260014r22","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/S0140-6736(23)01583-0","article-title":"Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomized, double-masked, phase 3 trial.","volume":"402","author":"Khanani","year":"2023","journal-title":"Lancet"},{"issue":"9","key":"eoi260014r23","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.oret.2020.12.002","article-title":"Geographic atrophy growth is strongly related to lesion perimeter: unifying effects of lesion area, number, and circularity on growth.","volume":"5","author":"Shen","year":"2021","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"eoi260014r24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1001\/jamaophthalmol.2013.572","article-title":"Square root transformation of geographic atrophy area measurements to eliminate dependence of growth rates on baseline lesion measurements: a reanalysis of Age-Related Eye Disease Study report no. 26.","volume":"131","author":"Feuer","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"13","key":"eoi260014r25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1167\/iovs.62.13.28","article-title":"Local progression kinetics of geographic atrophy depends upon the border location.","volume":"62","author":"Shen","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"eoi260014r26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ophtha.2024.07.014","article-title":"Oral antioxidant and lutein\/zeaxanthin supplements slow geographic atrophy progression to the fovea in age-related macular degeneration.","volume":"132","author":"Keenan","year":"2025","journal-title":"Ophthalmology"},{"issue":"3","key":"eoi260014r27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.oret.2024.11.006","article-title":"Alcohol consumption and risk of age-related macular degeneration and geographic atrophy progression: Age-Related Eye Diseases Study 2 report 34.","volume":"9","author":"Duic","year":"2025","journal-title":"Ophthalmol Retina"},{"issue":"5","key":"eoi260014r28","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3390\/nu17050771","article-title":"Relationships between diet and geographic atrophy progression in the Age-Related Eye Diseases Studies 1 and 2.","volume":"17","author":"Agr\u00f3n","year":"2025","journal-title":"Nutrients"},{"issue":"3","key":"eoi260014r29","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ophtha.2017.08.038","article-title":"The progression of geographic atrophy secondary to age-related macular degeneration.","volume":"125","author":"Fleckenstein","year":"2018","journal-title":"Ophthalmology"},{"issue":"11","key":"eoi260014r30","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1007\/s00417-024-06497-8","article-title":"Structural OCT and OCT angiography biomarkers associated with the development and progression of geographic atrophy in AMD.","volume":"262","author":"Vallino","year":"2024","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"eoi260014r31","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.ajo.2020.12.015","article-title":"Correlations between choriocapillaris and choroidal measurements and the growth of geographic atrophy using swept-source OCT imaging.","volume":"224","author":"Shi","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"eoi260014r32","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2025.100984","article-title":"Impact of reticular pseudodrusen on clinical and ocular characteristics and progression rate of geographic atrophy in Japanese patients.","volume":"6","author":"Ueda-Arakawa","year":"2025","journal-title":"Ophthalmol Sci"},{"issue":"4","key":"eoi260014r33","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2021.100057","article-title":"Local complement inhibition for geographic atrophy in age-related macular degeneration: prospects, challenges, and unanswered questions.","volume":"1","author":"Keenan","year":"2021","journal-title":"Ophthalmol Sci"},{"issue":"1","key":"eoi260014r34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.oret.2022.08.022","article-title":"Treating geographic atrophy\u2014are we ready? a call to image.","volume":"7","author":"Guymer","year":"2023","journal-title":"Ophthalmol Retina"},{"issue":"395","key":"eoi260014r35","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf1443","article-title":"Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration.","volume":"9","author":"Yaspan","year":"2017","journal-title":"Sci Transl Med"},{"issue":"9","key":"eoi260014r36","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1097\/IAE.0b013e3182509778","article-title":"Comparison of color fundus photographs and fundus autofluorescence images in measuring geographic atrophy area.","volume":"32","author":"Khanifar","year":"2012","journal-title":"Retina"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2846893\/jamaophthalmology_von_der_emde_2026_oi_260014_1778698668.18136.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:00:38Z","timestamp":1779375638000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2846893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2026.0540","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}